You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Biomarker Discovery: Ubiquitin Pathway Protein Microarrays

    SBC: LIFESENSORS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Bioinformatics and biochemical analysis suggests that the human genome encodes ~ 100 proteins known as deubiquitinating enzymes (DUBs). DUBs constitute an important class of enzymes that deconjugate ubiquitin and ubiquitin-like proteins (UBL) from their target proteins. Protein uniquitination serves many functions in the cell, including proteasome-mediated degr ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  2. Ergonomic backpacks for children and adults

    SBC: LIGHTNING PACKS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Despite modern conveniences, humans continue to transport considerable weight wherever they go. Although on smooth even surfaces, luggage with small wheels is effective, outside of these restricted arenas they are ineffective and add to the weight. Hence backpacks remain the preferred solution to move loads around with us. They are ubiquitous, carried by child ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. Intravesical Liposome Treatment for Interstitial Cystitis

    SBC: Lipella Pharmaceuticals Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a chronic, severely debilitating disease of the urinary bladder. It can be described as a chronic inflammatory condition of the bladder wall, characterized by urinary frequency and urgency, and severe suprapubic and/or pelvic pain. Presently, there is limited medical therapy for IC and new and effective treatment is a major unmet ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Bladder drug delivery using intravesical liposomes to treat overactive bladder

    SBC: Lipella Pharmaceuticals Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Lipella Pharmaceutical Inc has been successful with development of intravesical liposome for painful bladder syndrome/Interstitial cystitis (PBS/IC). Through SBIR funding, Lipella has been successful in establishing the pre-clinical safety of its primary liposome formulation LPA-08. LPA-08 was discovered at the University of Pittsburgh and exclusively licens ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. AMPK as a Target for Cancer Therapy

    SBC: LOCUS PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Hypoxia-inducible factor-1 (HIF-1) is the primary regulator of the transcriptional response of mammalian cells to low oxygen and other stresses that lower ATP levels. Our investigations on the mechanism of action of HIF -1 have led us to the fundamental observation that adenosine 5'-monophosphate-activated protein kinase (AMPK) activity is important for tumor b ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Prevention of Clostridium difficile-associated disease

    SBC: MIDI, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Clostridium difficile-associated disease (CDAD) is a hospital-acquired problem following routine antibiotic treatment. Its impact may exceed that of any other nosocomial infection. Spores of the toxin-producing pathogen are highly resistant to antibiotics and therefore overgrow the gut when broad-spectrum oral antibiotics kill off the competing bacteria. The C ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Resonance-driven Ocular Blade Reduces Ocular Tissue Trauma and Provides Consisten

    SBC: MICROMECHATRONICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Micromechatronics and Invengen Engineering will design and demonstrate a minimally invasive dynamic ocular blade that will use the 'reduction of force' effect to reduce tissue trauma. The long-term objective of this wor k is to commercialize two surgical procedure products; one used in cataract surgery, the other in the placement of central venous catheters. Th ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Development of a cost-effective pmMRI for in vivo structural examination of bone

    SBC: MICROMRI, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): MicroMRI, Inc. Development of a cost-effective pfMRI for in vivo structural examination of bone Abstract Osteoporosis is a systemic bone disease characterized by low bone mass and abnormal bone quality. The current "gold standard", dual-energy x-ray absorptiometry (DXA), cannot assess bone quality and fails to detect > 50% of persons at greatest risk of fractur ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. The ICU as a Learning Environment

    SBC: MOBERG RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to develop a novel system for critical care that delivers instructional material to healthcare personnel at the point of care. The overall goal is to shift some of the delivery of continuing education to the bedside, where relevant and often rich, untapped opportunities for context-based learning exist. The Phase II project will complete development ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Aggressive, invasive breast cancer will attack gt180,000 women in the US in 2007, and will take the lives of gt40,000 women. Mammograms detect lumps in breasts, H80% of which are benign, and H20% are malignant. Lumps ar e biopsied to determine whether they are benign or malignant. But biopsies do not determine which oncogenes are activated, and do not reliably ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government